Youth drinking in decline: What are the implications for public health, public policy and public debate?


Journal

The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759

Informations de publication

Date de publication:
04 2022
Historique:
received: 30 11 2021
revised: 21 01 2022
accepted: 26 01 2022
pubmed: 9 2 2022
medline: 6 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

Youth drinking has declined across most high-income countries in the last 20 years. Although researchers and commentators have explored the nature and drivers of decline, they have paid less attention to its implications. This matters because of the potential impact on contemporary and future public health, as well as on alcohol policy-making. This commentary therefore considers how youth drinking trends may develop in future, what this would mean for public health, and what it might mean for alcohol policy and debate. We argue that the decline in youth drinking is well-established and unlikely to reverse, despite smaller declines and stabilising trends in recent years. Young people also appear to be carrying their lighter drinking into adulthood in at least some countries. This suggests we should expect large short- and long-term public health benefits. The latter may however be obscured in population-level data by increased harm arising from earlier, heavier drinking generations moving through the highest risk points in the life course. The likely impact of the decline in youth drinking on public and policy debate is less clear. We explore the possibilities using two model scenarios, the reinforcement and withdrawal models. In the reinforcement model, a 'virtuous' circle of falling alcohol consumption, increasing public support for alcohol control policies and apparent policy successes facilitates progressive strengthening of policy, akin to that seen in the tobacco experience. In the withdrawal model, policy-makers turn their attention to other problems, public health advocates struggle to justify proposed interventions and existing policies erode over time as industry actors reassert and strengthen their partnerships with government around alcohol policy. We argue that disconnects between the tobacco experience and the reinforcement model make the withdrawal model a more plausible scenario. We conclude by suggesting some tentative ways forward for public health actors working in this space.

Identifiants

pubmed: 35131690
pii: S0955-3959(22)00026-3
doi: 10.1016/j.drugpo.2022.103606
pmc: PMC7612362
mid: EMS141043
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103606

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208090
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 208090/Z/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declarations of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

John Holmes (J)

School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK. Electronic address: john.holmes@sheffield.ac.uk.

Hannah Fairbrother (H)

Health Sciences School, University of Sheffield, Barber House, 387 Glossop Road, Sheffield, S10 2HQ, UK.

Michael Livingston (M)

National Drug Research Institute and enAble Institute, Faculty of Health Sciences, Curtin University, Perth, WA 6008, Australia; Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, 3803, Australia.

Petra Sylvia Meier (PS)

School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK; MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 99 Berkeley Square, Glasgow, G3 7HR, UK.

Melissa Oldham (M)

School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, S1 4DA, UK; Department of Behavioural Science and Health, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.

Amy Pennay (A)

Centre for Alcohol Policy Research, La Trobe University, Bundoora, Victoria, 3803, Australia.

Victoria Whitaker (V)

Health Sciences School, University of Sheffield, Barber House, 387 Glossop Road, Sheffield, S10 2HQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH